Showing results (71-80 of 357) with videos related to
Sort By:
Pageof 36
Blood Cancer Journal|November 1, 2024
Optimal infused CD34+ cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantationOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.JAMA Network Open|July 20, 2026
Mismatched Unrelated vs Matched Related Donor Transplant With Posttransplant Cyclophosphamide Among Patients With Blood CancersRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.Transplantation and Cellular Therapy|February 15, 2025
Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T CellsFrederick L Locke, Zahra Mahmoudjafari, Partow Kebriaei, et al.Leukemia|January 12, 2026
Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxisRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.Journal of Visualized Experiments : Jove|February 15, 2013
Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord bloodM Helen Huls, Matthew J Figliola, Margaret J Dawson, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2019
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host DiseasePartow Kebriaei, Jack Hayes, Andrew Daly, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?Piyanuch Kongtim, Antonio Di Stasi, Gabriela Rondon, et al.Blood Advances|June 15, 2025
Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxisYosra M Aljawai, Jeremy Ramdial, Gabriela Rondon, et al.British Journal of Haematology|May 10, 2006
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myelomaChitra Hosing, Muzaffar H Qazilbash, Partow Kebriaei, et al.American Journal of Hematology|May 15, 2021
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemiaNitin Jain, Abhishek Maiti, Farhad Ravandi, et al.Pageof 36